NWM
RDY icon

Navigoe Wealth Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Navigoe Wealth Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2K Hold
150
– – ﹤0.01% 172
2025
Q4 		$2K Hold
150
– – ﹤0.01% 210
2025
Q3 		$2K Buy
+150
New +$2.16K ﹤0.01% 208

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $70.2B AUM 29.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Navigoe Wealth Management's RDY Position: Q1 2026 in Review

Navigoe Wealth Management held its Dr. Reddy's Laboratories (RDY) position steady in Q1 2026 at 150 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #172.

Navigoe Wealth Management first reported a position in RDY in Q3 2025 and has held it in 3 quarters since. 247 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

  • Navigoe Wealth Management held 150 shares of Dr. Reddy's Laboratories worth $2K as of Q1 2026.
  • Navigoe Wealth Management left its Dr. Reddy's Laboratories share count unchanged in Q1 2026.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Navigoe Wealth Management's portfolio in Q1 2026, its #172 holding.
  • Navigoe Wealth Management first reported a position in Dr. Reddy's Laboratories in Q3 2025 and has held it in 3 quarters since.
  • 247 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on Navigoe Wealth Management's 13F filing for Q1 2026, filed 1 May 2026.